Work

Validation of a prognostic model for metastatic castrate-resistant prostate cancer (mCRPC) patients receiving abiraterone acetate (AA).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.5013

Authors: Praful Kumar Ravi, Joaquin Mateo, Zafeiris Zafeiriou, Amelia Altavilla, Roberta Ferraldeschi, Spyridon Sideris, Emily Grist, Alan D. Smith, Sophia Wong, David Lorente, Diletta Bianchini, Gerhardt Attard, Johann Sebastian De Bono

Institutions: Royal Marsden NHS Foundation Trust, Institute of Cancer Research

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2337208960

Cites:

Cited by:

Related to: 10